• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德斯布瓦氏发育不全中CANT1突变的鉴定。

Identification of CANT1 mutations in Desbuquois dysplasia.

作者信息

Huber Céline, Oulès Bénédicte, Bertoli Marta, Chami Mounia, Fradin Mélanie, Alanay Yasemin, Al-Gazali Lihadh I, Ausems Margreet G E M, Bitoun Pierre, Cavalcanti Denise P, Krebs Alexander, Le Merrer Martine, Mortier Geert, Shafeghati Yousef, Superti-Furga Andrea, Robertson Stephen P, Le Goff Carine, Muda Andrea Onetti, Paterlini-Bréchot Patrizia, Munnich Arnold, Cormier-Daire Valérie

机构信息

Paris Descartes University, Department of Genetics and INSERM U781 and U807, Hôpital Necker Enfants Malades, 75015 Paris, France.

出版信息

Am J Hum Genet. 2009 Nov;85(5):706-10. doi: 10.1016/j.ajhg.2009.10.001. Epub 2009 Oct 22.

DOI:10.1016/j.ajhg.2009.10.001
PMID:19853239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2775828/
Abstract

Desbuquois dysplasia is a severe condition characterized by short stature, joint laxity, scoliosis, and advanced carpal ossification with a delta phalanx. Studying nine Desbuquois families, we identified seven distinct mutations in the Calcium-Activated Nucleotidase 1 gene (CANT1), which encodes a soluble UDP-preferring nucleotidase belonging to the apyrase family. Among the seven mutations, four were nonsense mutations (Del 5' UTR and exon 1, p.P245RfsX3, p.S303AfsX20, and p.W125X), and three were missense mutations (p.R300C, p.R300H, and p.P299L) responsible for the change of conserved amino acids located in the seventh nucleotidase conserved region (NRC). The arginine substitution at position 300 was identified in five out of nine families. The specific function of CANT1 is as yet unknown, but its substrates are involved in several major signaling functions, including Ca2+ release, through activation of pyrimidinergic signaling. Importantly, using RT-PCR analysis, we observed a specific expression in chondrocytes. We also found electron-dense material within distended rough endoplasmic reticulum in the fibroblasts of Desbuquois patients. Our findings demonstrate the specific involvement of a nucleotidase in the endochondral ossification process.

摘要

德布凯发育不良是一种严重病症,其特征为身材矮小、关节松弛、脊柱侧弯以及伴有三角形指骨的腕骨骨化提前。通过对九个德布凯家族的研究,我们在钙激活核苷酸酶1基因(CANT1)中鉴定出七个不同的突变,该基因编码一种属于腺苷三磷酸双磷酸酶家族的偏好UDP的可溶性核苷酸酶。在这七个突变中,四个为无义突变(5'UTR和外显子1缺失、p.P245RfsX3、p.S303AfsX20和p.W125X),三个为错义突变(p.R300C、p.R300H和p.P299L),这些突变导致位于第七个核苷酸酶保守区域(NRC)的保守氨基酸发生改变。在九个家族中的五个家族中都鉴定出了第300位的精氨酸替代。CANT1的具体功能尚不清楚,但其底物参与了包括通过激活嘧啶能信号传导实现的Ca2+释放在内的几种主要信号传导功能。重要的是,通过逆转录聚合酶链反应(RT-PCR)分析,我们观察到其在软骨细胞中有特异性表达。我们还在德布凯患者的成纤维细胞中扩张的粗面内质网内发现了电子致密物质。我们的研究结果表明一种核苷酸酶在软骨内骨化过程中具有特异性作用。

相似文献

1
Identification of CANT1 mutations in Desbuquois dysplasia.德斯布瓦氏发育不全中CANT1突变的鉴定。
Am J Hum Genet. 2009 Nov;85(5):706-10. doi: 10.1016/j.ajhg.2009.10.001. Epub 2009 Oct 22.
2
CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant.CANT1 突变也与 Desbuquois 发育不良 2 型和 Kim 变异型有关。
J Med Genet. 2011 Jan;48(1):32-7. doi: 10.1136/jmg.2010.080226. Epub 2010 Oct 30.
3
MED resulting from recessively inherited mutations in the gene encoding calcium-activated nucleotidase CANT1.由编码钙激活核苷酸酶CANT1的基因中的隐性遗传突变导致的MED。
Am J Med Genet A. 2017 Sep;173(9):2415-2421. doi: 10.1002/ajmg.a.38349. Epub 2017 Jul 25.
4
A founder mutation of CANT1 common in Korean and Japanese Desbuquois dysplasia.韩国和日本德斯布瓦氏发育不良中常见的 CANT1 共同的创始突变。
J Hum Genet. 2011 May;56(5):398-400. doi: 10.1038/jhg.2011.28. Epub 2011 Mar 17.
5
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification.钙激活核苷酸酶 1(CANT1)对于软骨和软骨内骨化中的糖胺聚糖生物合成至关重要。
Matrix Biol. 2019 Aug;81:70-90. doi: 10.1016/j.matbio.2018.11.002. Epub 2018 Nov 12.
6
Desbuquois dysplasia type I and fetal hydrops due to novel mutations in the CANT1 gene.I 型德斯布夸综合征合并胎儿水肿与 CANT1 基因突变有关。
Eur J Hum Genet. 2011 Nov;19(11):1133-7. doi: 10.1038/ejhg.2011.101. Epub 2011 Jun 8.
7
XYLT1 mutations in Desbuquois dysplasia type 2.Desbuquois 发育不良 2 型中 XYLT1 突变。
Am J Hum Genet. 2014 Mar 6;94(3):405-14. doi: 10.1016/j.ajhg.2014.01.020. Epub 2014 Feb 27.
8
A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.三名患有金氏型德斯布凯发育不全的印度患者中发现一种新的CANT1突变。
Eur J Med Genet. 2015 Feb;58(2):105-10. doi: 10.1016/j.ejmg.2014.11.006. Epub 2014 Dec 5.
9
Mutation of CANT1 causes Desbuquois dysplasia.CANT1 突变导致德斯布瓦氏发育不良。
Am J Med Genet A. 2010 May;152A(5):1157-60. doi: 10.1002/ajmg.a.33404.
10
CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage.在 Desbuquois 发育不良的小鼠模型中 CANT1 缺乏会损害生长板软骨中的糖胺聚糖合成和软骨细胞分化。
FEBS Open Bio. 2020 Jun;10(6):1096-1103. doi: 10.1002/2211-5463.12859. Epub 2020 Apr 23.

引用本文的文献

1
CANT1 Is Involved in Collagen Fibrogenesis in Tendons by Regulating the Synthesis of Dermatan/Chondroitin Sulfate Attached to the Decorin Core Protein.CANT1通过调节附着于核心蛋白聚糖核心蛋白的硫酸皮肤素/硫酸软骨素的合成参与肌腱中的胶原纤维生成。
Int J Mol Sci. 2025 Mar 10;26(6):2463. doi: 10.3390/ijms26062463.
2
Clinical and Molecular Cytogenetic Characterization of 2 Sibling Cases with 17q25 Duplication due to Unbalanced Translocation.两例因不平衡易位导致17q25重复的同胞病例的临床和分子细胞遗传学特征
Mol Syndromol. 2024 Dec;15(6):495-502. doi: 10.1159/000538979. Epub 2024 May 30.
3
Genetic variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfate diversity.蛋白聚糖生物合成基因的遗传变异性揭示了硫酸乙酰肝素多样性的新方面。
Essays Biochem. 2024 Dec 4;68(4):555-578. doi: 10.1042/EBC20240106.
4
Cant1 Affects Cartilage Proteoglycan Properties: Aggrecan and Decorin Characterization in a Mouse Model of Desbuquois Dysplasia Type 1.Cant1 影响软骨蛋白聚糖特性:Desbuquois 发育不良 1 型小鼠模型中的聚集蛋白聚糖和核心蛋白聚糖的特征。
Biomolecules. 2024 Aug 26;14(9):1064. doi: 10.3390/biom14091064.
5
Clinical and Genetic Insights into Desbuquois Dysplasia: Review of 111 Case Reports.德斯布夸斯发育不良的临床与遗传学研究:111 例病例报告综述。
Int J Mol Sci. 2024 Sep 7;25(17):9700. doi: 10.3390/ijms25179700.
6
Circ_0001715 accelerated lung adenocarcinoma process by the miR-1322/CANT1 axis.环状 RNA 0001715 通过 miR-1322/CANT1 轴促进肺腺癌进程。
Diagn Pathol. 2023 Aug 8;18(1):91. doi: 10.1186/s13000-023-01348-2.
7
Deficiency of -Catalyzed Glycosaminoglycan Chain Synthesis in Neural Crest Leads to Cleft Palate.-Catalyzed 糖胺聚糖链合成缺陷导致神经嵴裂唇。
Int J Mol Sci. 2023 Jun 1;24(11):9634. doi: 10.3390/ijms24119634.
8
A Further Case of Larsen's Syndrome: Clinical and Genotypic Challenges in Diagnosis.拉森综合征的另一病例:诊断中的临床与基因分型挑战
J Pediatr Genet. 2020 Oct 19;11(4):298-303. doi: 10.1055/s-0040-1718540. eCollection 2022 Dec.
9
Prenatal Cases Reflect the Complexity of the Associated Osteogenesis Imperfecta.产前病例反映了相关成骨不全症的复杂性。
Genes (Basel). 2022 Sep 2;13(9):1578. doi: 10.3390/genes13091578.
10
Novel compound heterozygous variants in XYLT1 gene caused Desbuquois dysplasia type 2 in an aborted fetus: a case report.XYLT1 基因中的新型复合杂合变异导致流产胎儿出现 2 型德斯布夸斯发育不良:病例报告。
BMC Pediatr. 2022 Jan 26;22(1):63. doi: 10.1186/s12887-022-03132-5.

本文引用的文献

1
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis.隐性拉森综合征和肱骨-脊柱发育不全中由碳水化合物硫酸转移酶3缺乏引起的先天性关节脱位。
Am J Hum Genet. 2008 Jun;82(6):1368-74. doi: 10.1016/j.ajhg.2008.05.006.
2
Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation.
Biochem Pharmacol. 2008 May 15;75(10):1869-81. doi: 10.1016/j.bcp.2007.12.009. Epub 2008 Jan 3.
3
APY-1, a novel Caenorhabditis elegans apyrase involved in unfolded protein response signalling and stress responses.APY-1,一种参与未折叠蛋白反应信号传导和应激反应的新型秀丽隐杆线虫腺苷三磷酸双磷酸酶。
Mol Biol Cell. 2008 Apr;19(4):1337-45. doi: 10.1091/mbc.e07-06-0547. Epub 2008 Jan 23.
4
Calcium signaling.钙信号传导
Cell. 2007 Dec 14;131(6):1047-58. doi: 10.1016/j.cell.2007.11.028.
5
Nosology and classification of genetic skeletal disorders: 2006 revision.遗传性骨骼疾病的疾病分类学与分类:2006年修订版
Am J Med Genet A. 2007 Jan 1;143A(1):1-18. doi: 10.1002/ajmg.a.31483.
6
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.国际药理学联合会LVIII:P2Y G蛋白偶联核苷酸受体的最新进展:从分子机制、病理生理学到治疗
Pharmacol Rev. 2006 Sep;58(3):281-341. doi: 10.1124/pr.58.3.3.
7
Site-directed mutagenesis of human soluble calcium-activated nucleotidase 1 (hSCAN-1): identification of residues essential for enzyme activity and the Ca(2+)-induced conformational change.人可溶性钙激活核苷酸酶1(hSCAN-1)的定点诱变:确定酶活性和钙诱导构象变化所必需的残基
Biochemistry. 2004 Jul 20;43(28):9185-94. doi: 10.1021/bi049565o.
8
Structure and protein design of a human platelet function inhibitor.一种人血小板功能抑制剂的结构与蛋白质设计
Cell. 2004 Mar 5;116(5):649-59. doi: 10.1016/s0092-8674(04)00172-2.
9
Long-term outcome in Desbuquois dysplasia: a follow-up in four adult patients.德斯布瓦氏发育不良的长期预后:4例成年患者的随访
Am J Med Genet A. 2004 Jan 1;124A(1):54-9. doi: 10.1002/ajmg.a.20441.
10
Desbuquois dysplasia, a reevaluation with abnormal and "normal" hands: radiographic manifestations.德布凯发育不良:对异常和“正常”手部的重新评估及影像学表现
Am J Med Genet A. 2004 Jan 1;124A(1):48-53. doi: 10.1002/ajmg.a.20440.